The drug, one of the few nonhormonal options for menopausal women, reduced hot flashes and night sweats, and appears to help ...

US regulators approved GSK Plc’s blood cancer drug, a decision that will allow the company to bring the medicine back to the ...

A new drug combo of enzalutamide and hormone therapy has been shown to extend survival for men with recurring prostate cancer ...

A new drug combination cuts the risk of death in people with advanced prostate cancer by 40% over eight years, according to ...

A large new study found that the side effects of antidepressants vary significantly by drug. Some medications resulted in ...

In the recent SOUL trial, the GLP-1 drug reduced the risk of MACE by 14% over 4 years. Next up: a possible obesity indication ...

Millions of Americans take antidepressants. And like all medication, they come with side effects. Researchers studied 30 ...

Over 141,000 bottles of cholesterol medication have been recalled due to “failed dissolution specifications,” suggesting that ...

Researchers in the U.K. have published a major review of published data on physical side effects related to antidepressants such as changes in weight, blood pressure and heart rate.

Columnist Sam Kirton explains when the new FDA-approved IPF treatment Jascayd might be made available to patients.

As of Oct. 17, the FDA has approved more than a dozen glucagon-like peptide-1 receptor agonists for diabetes, weight loss, cardiovascular disease and other indications.